The companies will combine Nanoform’s Biologics platform with the Celanese VitalDose Drug Delivery platform to further optimize controlled release of biologics
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
Subscribe To Our Newsletter & Stay Updated
